| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $57.6M | +178.3% |
| SG&A Expense | $12.4M | -19.5% |
| Operating Income | -$70.7M | -93.0% |
| Pre-tax Income | -$68.3M | -92.6% |
| Income Tax | $1.0M | — |
| Net Income | -$69.4M | -95.5% |
| EPS (Basic) | -$4.71 | +61.3% |
| EPS (Diluted) | -$4.71 | +61.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $77.0M | +246.0% |
| Short-term Investments | $36.1M | +0.0% |
| Current Assets | $80.6M | +31.4% |
| Total Assets | $82.8M | +34.5% |
| Current Liabilities | $20.8M | +128.5% |
| Total Liabilities | $21.8M | +139.9% |
| Stockholders' Equity | $61.0M | +16.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.9M | -65.5% |
| Capital Expenditures | $116K | +213.5% |
| Investing Cash Flow | $36.2M | +200.7% |
| Financing Cash Flow | $69.4M | +33.8% |
| Free Cash Flow | -$51.0M | -65.7% |